Bexsero, meningitis B vaccine

Bexsero, meningitis B vaccine

C026/1659 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.9MB

Downloadable file size: 1.6MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only Not to be shared on social media or embedded in a web page without permission.

Caption: Bexsero, meningitis B vaccine. Packet of Bexsero, the meningococcal vaccine used against meningitis B, a disease caused by serogroup B of the Neisseria meningitidis bacterium. Meningitis is a potentially fatal inflammation of the brain membranes (meninges). This vaccine was developed by Novartis and approved for use in the European Union in January 2013. In the UK, it was added to the childhood immunisation programme from 1 September 2015.

Release details: Model release not required. Property release not required.

Keywords: 2015, 21st century, adsorbed, bacterial, bexsero, childhood, component, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, glaxosmithkline, group b, immunisation, immunization, intramuscular, medical, medicine, meningitis b, meningococcal, neisseria meningitidis, no-one, nobody, novartis, packaging, packet, paediatric, paediatrics, pediatrics, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pre-filled, rdna, serogroup b, still life, still-life, studio shot, suspension, syringe, text, vaccine, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.